IBDEI0C2 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5340,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5340,1,2,0)
 ;;=2^173.52
 ;;^UTILITY(U,$J,358.3,5340,1,5,0)
 ;;=5^SCC of skin of trunk
 ;;^UTILITY(U,$J,358.3,5340,2)
 ;;=^340480
 ;;^UTILITY(U,$J,358.3,5341,0)
 ;;=173.59^^25^324^24
 ;;^UTILITY(U,$J,358.3,5341,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5341,1,2,0)
 ;;=2^173.59
 ;;^UTILITY(U,$J,358.3,5341,1,5,0)
 ;;=5^Other spec neoplasm skin, trunk
 ;;^UTILITY(U,$J,358.3,5341,2)
 ;;=^340481
 ;;^UTILITY(U,$J,358.3,5342,0)
 ;;=173.60^^25^324^25
 ;;^UTILITY(U,$J,358.3,5342,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5342,1,2,0)
 ;;=2^173.60
 ;;^UTILITY(U,$J,358.3,5342,1,5,0)
 ;;=5^Malig neoplasm skin, arm/shoulder
 ;;^UTILITY(U,$J,358.3,5342,2)
 ;;=^340602
 ;;^UTILITY(U,$J,358.3,5343,0)
 ;;=173.61^^25^324^26
 ;;^UTILITY(U,$J,358.3,5343,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5343,1,2,0)
 ;;=2^173.61
 ;;^UTILITY(U,$J,358.3,5343,1,5,0)
 ;;=5^BCC of skin of arm/shoulder
 ;;^UTILITY(U,$J,358.3,5343,2)
 ;;=^340482
 ;;^UTILITY(U,$J,358.3,5344,0)
 ;;=173.62^^25^324^27
 ;;^UTILITY(U,$J,358.3,5344,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5344,1,2,0)
 ;;=2^173.62
 ;;^UTILITY(U,$J,358.3,5344,1,5,0)
 ;;=5^SCC of skin of arm/shoulder
 ;;^UTILITY(U,$J,358.3,5344,2)
 ;;=^340483
 ;;^UTILITY(U,$J,358.3,5345,0)
 ;;=173.69^^25^324^28
 ;;^UTILITY(U,$J,358.3,5345,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5345,1,2,0)
 ;;=2^173.69
 ;;^UTILITY(U,$J,358.3,5345,1,5,0)
 ;;=5^Other spec neoplasm skin, arm/shoulder
 ;;^UTILITY(U,$J,358.3,5345,2)
 ;;=^340484
 ;;^UTILITY(U,$J,358.3,5346,0)
 ;;=173.70^^25^324^29
 ;;^UTILITY(U,$J,358.3,5346,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5346,1,2,0)
 ;;=2^173.70
 ;;^UTILITY(U,$J,358.3,5346,1,5,0)
 ;;=5^Malig neoplasm skin, leg/hip
 ;;^UTILITY(U,$J,358.3,5346,2)
 ;;=^340603
 ;;^UTILITY(U,$J,358.3,5347,0)
 ;;=173.71^^25^324^30
 ;;^UTILITY(U,$J,358.3,5347,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5347,1,2,0)
 ;;=2^173.71
 ;;^UTILITY(U,$J,358.3,5347,1,5,0)
 ;;=5^BCC of skin of leg/hip
 ;;^UTILITY(U,$J,358.3,5347,2)
 ;;=^340485
 ;;^UTILITY(U,$J,358.3,5348,0)
 ;;=173.72^^25^324^31
 ;;^UTILITY(U,$J,358.3,5348,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5348,1,2,0)
 ;;=2^173.72
 ;;^UTILITY(U,$J,358.3,5348,1,5,0)
 ;;=5^SCC of skin of leg/hip
 ;;^UTILITY(U,$J,358.3,5348,2)
 ;;=^340486
 ;;^UTILITY(U,$J,358.3,5349,0)
 ;;=173.79^^25^324^32
 ;;^UTILITY(U,$J,358.3,5349,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5349,1,2,0)
 ;;=2^173.79
 ;;^UTILITY(U,$J,358.3,5349,1,5,0)
 ;;=5^Other spec neoplasm skin, leg/hip
 ;;^UTILITY(U,$J,358.3,5349,2)
 ;;=^340487
 ;;^UTILITY(U,$J,358.3,5350,0)
 ;;=173.80^^25^324^33
 ;;^UTILITY(U,$J,358.3,5350,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5350,1,2,0)
 ;;=2^173.80
 ;;^UTILITY(U,$J,358.3,5350,1,5,0)
 ;;=5^Malig neoplasm skin, other sites NOS
 ;;^UTILITY(U,$J,358.3,5350,2)
 ;;=^340604
 ;;^UTILITY(U,$J,358.3,5351,0)
 ;;=173.81^^25^324^34
 ;;^UTILITY(U,$J,358.3,5351,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5351,1,2,0)
 ;;=2^173.81
 ;;^UTILITY(U,$J,358.3,5351,1,5,0)
 ;;=5^BCC of skin of specified sites
 ;;^UTILITY(U,$J,358.3,5351,2)
 ;;=^340488
 ;;^UTILITY(U,$J,358.3,5352,0)
 ;;=173.82^^25^324^35
 ;;^UTILITY(U,$J,358.3,5352,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5352,1,2,0)
 ;;=2^173.82
 ;;^UTILITY(U,$J,358.3,5352,1,5,0)
 ;;=5^SCC of skin of specified sites
 ;;^UTILITY(U,$J,358.3,5352,2)
 ;;=^340489
 ;;^UTILITY(U,$J,358.3,5353,0)
 ;;=173.89^^25^324^36
 ;;^UTILITY(U,$J,358.3,5353,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5353,1,2,0)
 ;;=2^173.89
 ;;^UTILITY(U,$J,358.3,5353,1,5,0)
 ;;=5^Other spec neoplasm skin, other sites
 ;;
 ;;$END ROU IBDEI0C2
